SEC Form 4 · accession 0001702626-18-000005
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stewart Appelrouth
Director
Period of report
Nov 5, 2018
Accepted (ET)
Nov 6, 2018 · 11:24 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 5, 2018 | P | 25,238 | $0.22 | A | 266,988 | D |
Table II — derivative securities
No Table II lines on this filing.